Cefepime-Resistant Pseudomonas aeruginosa
Resistance to extended-spectrum cephalosporins complicates treatment of Pseudomonas aeruginosa infections. To elucidate risk factors for cefepime-resistant P. aeruginosa and determine its association with patient death, we conducted a case–control study in Philadelphia, Pennsylvania. Among 2,529 pat...
Main Authors: | Ehimare Akhabue, Marie Synnestvedt, Mark G. Weiner, Warren B. Bilker, Ebbing Lautenbach |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2011-06-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/17/6/10-0358_article |
Similar Items
-
Risk factors for healthcare-associated infections caused by cefepime-resistant Pseudomonas aeruginosa
by: Folić Marko M., et al.
Published: (2020-01-01) -
Influence of borderline cefepime MIC on the outcome of cefepime-susceptible Pseudomonas aeruginosa bacteremia treated with a maximal cefepime dose: a hospital-based retrospective study
by: Ting-Yi Su, et al.
Published: (2017-07-01) -
Synergistic Effects of Gentamicin, Cefepime, and Ciprofloxacin on Biofilm of Pseudomonas aeruginosa
by: Usman M, et al.
Published: (2023-09-01) -
Transcending the challenge of evolving resistance mechanisms in Pseudomonas aeruginosa through β-lactam-enhancer-mechanism-based cefepime/zidebactam
by: Andrea M. Hujer, et al.
Published: (2023-12-01) -
Antimicrobial Resistance Pattern of Pseudomonas aeruginosa: An 11-Year Experience in a Tertiary Care Hospital in Makkah, Saudi Arabia
by: Momenah AM, et al.
Published: (2023-06-01)